Effects of the PPARα agonist WY-14,643 on plasma lipids, enzymatic activities and mRNA expression of lipid metabolism genes in a marine flatfish, Scophthalmus maximus
- 1 July 2015
- journal article
- Published by Elsevier in Aquatic Toxicology
- Vol. 164, 155-162
Abstract
No abstract availableKeywords
Funding Information
- Portuguese Foundation for Science and Technology (FCT) (PEst-C/MAR/LA0015/2013)
- Regional Development Fund
This publication has 42 references indexed in Scilit:
- Perfluorooctane sulfonate impairs the cardiac development of a marine medaka (Oryzias melastigma)Aquatic Toxicology, 2011
- Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (Danio rerio)Aquatic Toxicology, 2011
- The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow troutToxicology and Applied Pharmacology, 2011
- Minireview: The Case for ObesogensMolecular Endocrinology, 2009
- The physiology of long-distance migration: extending the limits of endurance metabolismJournal of Experimental Biology, 2009
- Genomic Profiling Reveals an Alternate Mechanism for Hepatic Tumor Promotion by Perfluorooctanoic Acid in Rainbow TroutEnvironmental Health Perspectives, 2008
- Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonistsBMC Bioinformatics, 2006
- The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesisMolecular and Cellular Endocrinology, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Circannual variation in the fatty acid composition of high-density lipoprotein phospholipids during acclimatization in troutBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993